Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for traumatic brain contusion
IRCT20181225042112N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tranexamic acid in traumatic brain injury (TBI) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Prevention or slowing of brain contusion evolution. Started Dec 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20181225042112N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181225042112N1.